Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.365
-0.215 (-4.69%)
Oct 6, 2026, 12:48 PM EDT - Market open
Myriad Genetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 418 | 573 | 1,248 | 1,697 | 1,176 | 2,204 | |
Market Cap Growth | -41.95% | -54.07% | -26.46% | 44.34% | -46.65% | 48.19% |
Enterprise Value | 513 | 640 | 1,291 | 1,812 | 1,054 | 1,884 |
Last Close Price | 4.58 | 6.15 | 13.71 | 19.14 | 14.51 | 27.60 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 196.49 | 141.34 | 247.70 | 230.87 | 139.81 |
PS Ratio | 0.54 | 0.70 | 1.49 | 2.25 | 1.73 | 3.19 |
PB Ratio | 1.44 | 1.56 | 1.78 | 2.17 | 1.33 | 2.28 |
P/TBV Ratio | 3.72 | 3.52 | 8.19 | 11.98 | 5.54 | 6.94 |
P/FCF Ratio | - | - | - | - | - | 3673.31 |
P/OCF Ratio | 56.89 | 318.48 | - | - | - | 118.49 |
PEG Ratio | - | 1.98 | 2.02 | 2.62 | 2.62 | 2.62 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.66 | 0.78 | 1.54 | 2.41 | 1.55 | 2.73 |
EV/FCF Ratio | - | - | - | - | - | 3139.65 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.69 | 0.57 | 0.20 | 0.19 | 0.16 | 0.10 |
Debt / EBITDA Ratio | - | 65.56 | - | - | - | - |
Debt / FCF Ratio | - | - | - | - | - | 153.83 |
Net Debt / Equity Ratio | 0.31 | 0.16 | 0.05 | 0.01 | -0.03 | -0.32 |
Net Debt / EBITDA Ratio | -2.37 | -4.27 | -1.41 | -0.13 | 0.35 | 4.78 |
Net Debt / FCF Ratio | -13.05 | -4.36 | -1.37 | -0.06 | 0.16 | -509.17 |
Asset Turnover | 1.23 | 0.95 | 0.77 | 0.64 | 0.54 | 0.50 |
Inventory Turnover | 8.48 | 8.53 | 10.19 | 11.22 | 11.41 | 9.32 |
Quick Ratio | 1.72 | 1.98 | 1.36 | 1.64 | 1.58 | 2.11 |
Current Ratio | 2.21 | 2.49 | 1.82 | 2.01 | 2.00 | 2.37 |
Return on Equity (ROE) | -32.54% | -68.45% | -17.15% | -31.55% | -12.08% | -2.94% |
Return on Assets (ROA) | -8.60% | -4.89% | -5.06% | -7.71% | -6.14% | -5.78% |
Return on Invested Capital (ROIC) | -21.97% | -11.62% | -11.48% | -16.91% | -15.11% | -14.56% |
Return on Capital Employed (ROCE) | -17.80% | -11.80% | -10.20% | -14.60% | -11.70% | -11.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -25.70% | -63.83% | -10.20% | -15.52% | -9.53% | -1.23% |
FCF Yield | -1.67% | -2.41% | -2.22% | -10.26% | -12.89% | 0.03% |
Buyback Yield / Dilution | -2.46% | -2.21% | -9.42% | -2.73% | -3.33% | -4.31% |